$1.69
0.159.74%
At close: -
$1.61
-0.08-4.73%
After Hours: Dec 20, 7:26 PM EDT
Pyxis Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pyxis Oncology using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.35 | $-0.30 | -16.7 % |
Jun 2024 | 2024-08-14 | $-0.29 | $-0.28 | -3.57 % |
Mar 2024 | 2024-05-14 | $-0.06 | $-0.22 | 72.7 % |
Dec 2023 | 2024-03-21 | $-0.33 | $-0.47 | 29.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $16.15M | $4.12M | 291.9 % |
Dec 2023 | 2024-03-21 | $0 | $170.00K | -100.0 % |
Pyxis Oncology (PYXS) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.35, which missed the estimate of $-0.30.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.